BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, will hold its 2020 Annual Meeting of Stockholders in a virtual meeting format on Wednesday, June 3, 2020 at 10:00 a.m. (Eastern Time) at www.viewproxy.com/AnnovisBio/2020/VM.
Shareholders of record that attend the Annual Meeting will be able to vote and submit questions during the meeting by using the Virtual Control Number provided with the Notice of Internet Availability of Proxy Materials.
Shareholders are encouraged to read the Proxy Statement and vote prior to the Annual Meeting to ensure their shares will be represented. For most items, including the election of directors, shares will not be voted unless stockholders provide voting instructions via the Internet or by returning a proxy card or voting instruction card.
The Notice of Annual Meeting, Proxy Statement and Annual Report on Form 10-K for the year ended December 31, 2019 are available at www.AALvote.com/ANVS.
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.